The expression of c-Myc and TCF-1, downstream target genes of Wnt/β-catenin signaling, was analyzed after treating the cervical cancer cells with IWR-1-endo, a Wnt/β-catenin signaling inhibitor, in the presence or absence of NHERF1 expression. This evidence concerns the gene NHERF1 and cervical cancer.